Abstract:Background: Urolithin B, gut microbiota metabolite of ellagitannins, contributes toward multiple health benefits attributed to ellagitannin-rich foods, has various bioactivities such as anti-inflammatory and anti-aging effects. This study was to investigate the effect of urolithin B on renal fibrosis and the underlying mechanism. Methods: In vivo, unilateral ureteral obstruction (UUO) model was established with or without urolithin B treatment for three weeks. Then, changes in the kidney function and renal pathology were investigated. In vitro, the HK-2 cells were treated with TGF-β1 (10 ng/ml) for 24 h with or without urolithin B administration. Next cell damage and proliferation was evaluated. Findings: In vivo, after urolithin B treatment, UUO-induced kidney injury was significantly ameliorated as shown by the improvement of renal function (BUN and serum creatinine), kidney morphology and the suppression of renal tubular injury markers of TGF-β1, Ang II, α-SMA and Col IV. Meanwhile, the renal inflammatory induced by UUO were also strikingly attenuated in urolithin B-treated rats (TNF-α, IL-6 and MCP-1). In vitro, urolithin B treatment markedly inhibited TGF-β1-induced HK-2 cells fibrosis and proliferation, suppressed TGF-β1 and NF-κB activation. Interpretation: This works suggested that urolithin B contributes critically to the development of chronic kidney pathologies induced by UUO, and modulating TGF-β/Smad and TLR4/NF-κB signaling possibly represent a potential therapeutic strategy to impede renal fibrosis transition. Funding: This work was supported by a grant from the National Natural Science Foundation of China (no. 31770381). Declaration of Interest: The authors declare that there are no conflicts of interest. Ethical Approval: All animal experiment were approved by the ethics committee of Wu Han University, Wu Han, China, and carried in accordance with National institutes of health guide for the care and use of laboratory animals.

Gut Microbial Metabolite Urolithin B Attenuates Intestinal Immunity Function in Vivo in Aging Mice and in Vitro in HT29 Cells by Regulating Oxidative Stress and Inflammatory Signalling.

Gut microbial metabolite urolithin B attenuates intestinal immunity function <i>in vivo</i> in aging mice and <i>in vitro</i> in HT29 cells by regulating oxidative stress and inflammatory signalling (vol 12, pg 11938, 2021)

The ellagitannin metabolite urolithin C attenuated cognitive impairment by inhibiting neuroinflammation via downregulation of MAPK/NF-kB signaling pathways in aging mice

Inhibition of the NF-κB and mTOR targets by urolithin A attenuates D-galactose-induced aging in mice

Ameliorative Effect of Urolithin A Ond-Gal-induced Liver and Kidney Damage in Aging Miceviaits Antioxidative, Anti-Inflammatory and Antiapoptotic Properties

The Gut Microbiota Metabolite Urolithin B Improves Cognitive Deficits by Inhibiting Cyt C-Mediated Apoptosis and Promoting the Survival of Neurons Through the PI3K Pathway in Aging Mice

Urolithin B Protects Mice from Diet-Induced Obesity, Insulin Resistance, and Intestinal Inflammation by Regulating Gut Microbiota Composition.

Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates D-Galactose-Induced Brain Aging in Mice

Protective effect of urolithin a on cisplatin-induced nephrotoxicity in mice via modulation of inflammation and oxidative stress

Methylated urolithin A, mitigates cognitive impairment by inhibiting NLRP3 inflammasome and ameliorating mitochondrial dysfunction in aging mice

Gut microbial metabolite urolithin B protects from insulin resistance and intestinal inflammation in association reshaping gut microbiota of obseity mice

Activation of the Gut–Brain Interaction by Urolithin A and Its Molecular Basis

Anti-renal Fibrosis and Anti-Inflammation Effect of Urolithin B, Ellagitannin-Gut Microbial-Derived Metabolites in Unilateral Ureteral Obstruction Rats

Urolithins Attenuate LPS-Induced Neuroinflammation in BV2Microglia via MAPK, Akt, and NF-κB Signaling Pathways.

Anti-Renal Fibrosis Effect of Urolithin B, Ellagitannin-Gut Microbial-Derived Metabolites, via TGF-β1/Smad and TLR4/NF-κb Signaling Pathways in a Rat Model of Unilateral Ureteral Obstruction

Gut metabolite Urolithin A mitigates ionizing radiation-induced intestinal damage

Urolithin A Inactivation of TLR3/TRIF Signaling to Block the NF-κB/STAT1 Axis Reduces Inflammation and Enhances Antioxidant Defense in Poly(I:C)-Induced RAW264.7 Cells

Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases

Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins

Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages

In Vivo Antioxidant Activity of Cinnamomum Cassia Leaf Residues and Their Effect on Gut Microbiota of D-Galactose-induced Aging Model Mice.